Xi Jinping: China open to 'vaccine cooperation' with Eastern Europe

China is ready to consider vaccine cooperation with Central and Eastern European countries, President Xi Jinping said Tuesday

Xi Jinping
Chinese President Xi Jinping
AP | PTI Beijing
2 min read Last Updated : Feb 09 2021 | 7:56 PM IST

China is ready to consider vaccine cooperation with Central and Eastern European countries, President Xi Jinping said Tuesday in a meeting held by video link with European leaders.

Serbia has received 1 million doses of a Chinese-developed coronavirus vaccine and Hungarian and Chinese vaccine developers are cooperating, Xi said, according to the official Xinhua News Agency.

Beijing will actively consider such cooperation with other governments, he was quoted as saying at the Summit of China and Central and Eastern European Countries.

China has given conditional approval for two vaccines made by two state-owned developers, Sinopharm and Sinovac. They have struck deals to supply millions of doses to Turkey and at least nine other countries.

Beijing is trying to nurture relations with Central and Eastern European governments as part of efforts to expand markets for exports and for Chinese construction and other companies to operate abroad.

The focus on Eastern Europe through the China-CEEC group, also known as 17 plus 1, has prompted unease among France, Germany and other Western European governments that Beijing is trying to make political inroads into the European Union.

Meanwhile, Xi said China intends to import farm and other goods worth more than USD 170 billion from Central and Eastern Europe over the next five years, according to Xinhua.

Beijing is trying to develop new trade relationships and reduce reliance on the United States following a tariff war with Washington.

We need to deepen agricultural cooperation, Xi said, according to Xinhua.

Xi also expressed support for plans by Fudan University in Shanghai to establish a university in Hungary.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Xi JinpingCoronavirus VaccineEurope

First Published: Feb 09 2021 | 7:52 PM IST

Next Story